Inspire Investing’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-13,797
| Closed | -$2.64M | – | 795 |
|
|
2023
Q4 | $2.64M | Buy |
13,797
+339
| +3% | +$64.9K | 0.29% | 75 |
|
|
2023
Q3 | $2.38M | Sell |
13,458
-6,401
| -32% | -$1.13M | 0.3% | 69 |
|
|
2023
Q2 | $3.77M | Buy |
19,859
+3,404
| +21% | +$647K | 0.46% | 51 |
|
|
2023
Q1 | $3.3M | Buy |
16,455
+1,631
| +11% | +$327K | 0.42% | 53 |
|
|
2022
Q4 | $3.52M | Buy |
14,824
+1,352
| +10% | +$321K | 0.45% | 44 |
|
|
2022
Q3 | $2.7M | Sell |
13,472
-1,126
| -8% | -$225K | 0.38% | 58 |
|
|
2022
Q2 | $2.13M | Sell |
14,598
-1,135
| -7% | -$166K | 0.28% | 78 |
|
|
2022
Q1 | $2.57M | Sell |
15,733
-2,803
| -15% | -$458K | 0.3% | 78 |
|
|
2021
Q4 | $3.14M | Buy |
18,536
+3,781
| +26% | +$641K | 0.36% | 73 |
|
|
2021
Q3 | $2.79M | Buy |
+14,755
| New | +$2.79M | 0.35% | 69 |
|